• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2017 Fiscal Year Annual Research Report

Comprehensive analysis of druggable tyrosine kinase in idiopathic interstitial pneumonia

Research Project

Project/Area Number 16K15458
Research InstitutionOkayama University

Principal Investigator

木浦 勝行  岡山大学, 大学病院, 教授 (10243502)

Co-Investigator(Kenkyū-buntansha) 大橋 圭明  岡山大学, 大学病院, 講師 (60729193)
久保 寿夫  岡山大学, 大学病院, 助教 (90726928)
Project Period (FY) 2016-04-01 – 2018-03-31
Keywords特発性肺線維症
Outline of Annual Research Achievements

マルチキナーゼ阻害剤であるニンテダニブは、特発性肺線維症の進行抑制効果があることが複数の第Ⅲ相試験で示されている。特発性肺線維症の進展にkinase遺伝子が関連している可能性があることから、次世代シーケンサーを用いて、特発性肺線維症肺と正常肺のkinase遺伝子発現について網羅的に比較検討を行った。RNAlaterで保存した特発性肺線維症肺13サンプルおよび正常肺(肺癌手術摘出肺の残余部)8サンプルからRNAを抽出し、SureSelect Human Kinome RNA Kit(Agilent Techonologies)を用いてライブラリを作成した。MiSeq(illimina)を用いてシーケンスを行い、特発性肺線維症肺において発現量に有意な差のあるkinase遺伝子を複数見出している。これらの遺伝子発現は蛋白レベル(免疫染色)でも確認を行い、概ねシーケンス結果と矛盾の無い結果であった。
ただし、様々な細胞を含む肺組織ブロックでの遺伝子発現解析では、特発性肺線維症肺と正常肺の細胞構成の違いが、遺伝子発現解析結果に大きく影響する事が判明した。この影響を取り除くためには、単一の細胞集団を抽出して、それぞれの細胞種ごとに解析を行う必要がある。慢性的な肺胞上皮の障害が特発性肺線維症のトリガーとなるとされていることから、今回は肺胞上皮に着目した。レーザーマイクロダイセクション法(LMD7000、Leica Microsystems)を用いて、特発性肺線維症および正常肺の肺胞上皮を切り出し、RNAを抽出した。抽出したRNAを用いてTruSeq RNA access(illumina)でライブラリを作成し、遺伝子発現解析を行った(HiSeq 4000、illimina)。シーケンスはすでに終了しており、データ解析も終了し論文作成中である。

  • Research Products

    (17 results)

All 2018 2017

All Journal Article (14 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 14 results) Presentation (3 results) (of which Int'l Joint Research: 3 results)

  • [Journal Article] Second primary cancer in survivors of locally advanced non-small cell lung cancer treated with concurrent chemoradiation followed by surgery2018

    • Author(s)
      Makimoto Go、Kubo Toshio、Oze Isao、Ohashi Kadoaki、Hotta Katsuyuki、Tabata Masahiro、Soh Junichi、Toyooka Shinichi、Katsui Kuniaki、Takigawa Nagio、Tanimoto Mitsune、Kiura Katsuyuki
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 48 Pages: 287~290

    • DOI

      10.1093/jjco/hyy003

    • Peer Reviewed
  • [Journal Article] MET or NRAS amplification is an acquired resistance mechanism to the third-generation EGFR inhibitor naquotinib2018

    • Author(s)
      Ninomiya Kiichiro、Ohashi Kadoaki、Makimoto Go、Tomida Shuta、Higo Hisao、Kayatani Hiroe、Ninomiya Takashi、Kubo Toshio、Ichihara Eiki、Hotta Katsuyuki、Tabata Masahiro、Maeda Yoshinobu、Kiura Katsuyuki
    • Journal Title

      Scientific Reports

      Volume: 8 Pages: on line

    • DOI

      10.1038/s41598-018-20326-z

    • Peer Reviewed
  • [Journal Article] Phase 3 study of ceritinib vs chemotherapy in ALK-rearranged NSCLC patients previously treated with chemotherapy and crizotinib (ASCEND-5): Japanese subset2018

    • Author(s)
      Kiura Katsuyuki、Imamura Fumio、Kagamu Hiroshi、Matsumoto Shingo、Hida Toyoaki、Nakagawa Kazuhiko、Satouchi Miyako、Okamoto Isamu、Takenoyama Mitsuhiro、Fujisaka Yasuhito、Kurata Takayasu、Ito Masayuki、Tokushige Kota、Hatano Ben、Nishio Makoto
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 48 Pages: 367~375

    • DOI

      10.1093/jjco/hyy016

    • Peer Reviewed
  • [Journal Article] Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samples2018

    • Author(s)
      Kiura Katsuyuki、Yoh Kiyotaka、Katakami Nobuyuki、Nogami Naoyuki、Kasahara Kazuo、Takahashi Toshiaki、Okamoto Isamu、Cantarini Mireille、Hodge Rachel、Uchida Hirohiko
    • Journal Title

      Cancer Science

      Volume: 109 Pages: 1177~1184

    • DOI

      10.1111/cas.13511

    • Peer Reviewed
  • [Journal Article] Randomized, Double-Blind Phase Ib/III Study of Erlotinib With Ramucirumab or Placebo in Previously Untreated EGFR -Mutant Metastatic Non-Small-Cell Lung Cancer (RELAY): Phase Ib Results2018

    • Author(s)
      Reck Martin、Garon Edward B.、Paz-Ares Luis、Ponce Santiago、Jaime Jesus Corral、Juan Oscar、Nadal Ernest、Kiura Katsuyuki、Widau Ryan C.、He Shuang、Dalal Rita、Lee Pablo、Nakagawa Kazuhiko
    • Journal Title

      Clinical Lung Cancer

      Volume: 19 Pages: 213~220.e4

    • DOI

      10.1016/j.cllc.2017.11.003

    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] A Phase II Study of Trastuzumab Emtansine in HER2-Positive Non-Small Cell Lung Cancer2018

    • Author(s)
      Hotta Katsuyuki、Aoe Keisuke、Kozuki Toshiyuki、Ohashi Kadoaki、Ninomiya Kiichiro、Ichihara Eiki、Kubo Toshio、Ninomiya Takashi、Chikamori Kenichi、Harada Daijiro、Nogami Naoyuki、Hirata Taizo、Hinotsu Shiro、Toyooka Shinichi、Kiura Katsuyuki
    • Journal Title

      Journal of Thoracic Oncology

      Volume: 13 Pages: 273~279

    • DOI

      10.1016/j.jtho.2017.10.032

    • Peer Reviewed
  • [Journal Article] A phase I trial of afatinib and bevacizumab in chemo-naive patients with advanced non-small-cell lung cancer harboring EGFR mutations: Okayama Lung Cancer Study Group Trial 14042018

    • Author(s)
      Ninomiya Takashi、Nogami Naoyuki、Kozuki Toshiyuki、Harada Daijiro、Kubo Toshio、Ohashi Kadoaki、Kuyama Shoichi、Kudo Kenichiro、Bessho Akihiro、Fukamatsu Nobuaki、Fujimoto Nobukazu、Aoe Keisuke、Shibayama Takuo、Sugimoto Keisuke、Takigawa Nagio、Hotta Katsuyuki、Kiura Katsuyuki
    • Journal Title

      Lung Cancer

      Volume: 115 Pages: 103~108

    • DOI

      10.1016/j.lungcan.2017.11.025

    • Peer Reviewed
  • [Journal Article] Potential influence of interleukin-6 on the therapeutic effect of gefitinib in patients with advanced non-small cell lung cancer harbouring EGFR mutations2018

    • Author(s)
      Tamura Tomoki、Kato Yuka、Ohashi Kadoaki、Ninomiya Kiichiro、Makimoto Go、Gotoda Hiroko、Kubo Toshio、Ichihara Eiki、Tanaka Takehiro、Ichimura Koichi、Maeda Yoshinobu、Hotta Katsuyuki、Kiura Katsuyuki
    • Journal Title

      Biochemical and Biophysical Research Communications

      Volume: 495 Pages: 360~367

    • DOI

      10.1016/j.bbrc.2017.10.175

    • Peer Reviewed
  • [Journal Article] A phase II trial of carboplatin plus S-1 for elderly patients with advanced non-small-cell lung cancer with wild-type epidermal growth factor receptor: The Okayama Lung Cancer Study Group Trial 12022017

    • Author(s)
      Kuyama Shoichi、Ochi Nobuaki、Bessho Akihiro、Hotta Katsuyuki、Ikeda Genyo、Kishino Daizo、Kubo Toshio、Harada Daijiro、Fujimoto Nobukazu、Nakanishi Masamoto、Umeno Takahiro、Okada Toshiaki、Chikamori Kenichi、Yamagishi Tomoko、Ohashi Kadoaki、Ichihara Eiki、Takigawa Nagio、Tanimoto Mitsune、Kiura Katsuyuki
    • Journal Title

      Lung Cancer

      Volume: 112 Pages: 188~194

    • DOI

      10.1016/j.lungcan.2017.08.010

    • Peer Reviewed
  • [Journal Article] Clinical characteristics of Japanese candidates for lung transplant for interstitial lung disease and risk factors for early death while on the waiting list2017

    • Author(s)
      Higo Hisao、Kurosaki Takeshi、Ichihara Eiki、Kubo Toshio、Miyoshi Kentaroh、Otani Shinji、Sugimoto Seiichiro、Yamane Masaomi、Miyahara Nobuaki、Kiura Katsuyuki、Miyoshi Shinichiro、Oto Takahiro
    • Journal Title

      Respiratory Investigation

      Volume: 55 Pages: 264~269

    • DOI

      10.1016/j.resinv.2017.03.002

    • Peer Reviewed
  • [Journal Article] Ceritinib versus chemotherapy in patients with ALK -rearranged non-small-cell lung cancer previously given chemotherapy and crizotinib (ASCEND-5): a randomised, controlled, open-label, phase 3 trial2017

    • Author(s)
      Shaw Alice T、Kim Tae Min、Crino Lucio、Gridelli Cesare、Kiura Katsuyuki、Liu Geoffrey、Novello Silvia、Bearz Alessandra、Gautschi Oliver、Mok Tony、Nishio Makoto、Scagliotti Giorgio、Spigel David R、Deudon Stephanie、Zheng Cheng、Pantano Serafino、Urban Patrick、Massacesi Cristian、et al.
    • Journal Title

      The Lancet Oncology

      Volume: 18 Pages: 874~886

    • DOI

      10.1016/S1470-2045(17)30339-X

    • Peer Reviewed / Int'l Joint Research
  • [Journal Article] Triplet therapy with afatinib, cetuximab, and bevacizumab induces deep remission in lung cancer cells harboring EGFR T790M in vivo2017

    • Author(s)
      Kudo Kenichiro、Ohashi Kadoaki、Makimoto Go、Higo Hisao、Kato Yuka、Kayatani Hiroe、Kurata Yasuko、Takami Yoichiro、Minami Daisuke、Ninomiya Takashi、Kubo Toshio、Ichihara Eiki、Sato Akiko、Hotta Katsuyuki、Yoshino Tadashi、Tanimoto Mitsune、Kiura Katsuyuki
    • Journal Title

      Molecular Oncology

      Volume: 11 Pages: 670~681

    • DOI

      10.1002/1878-0261.12063

    • Peer Reviewed
  • [Journal Article] Ceritinib in patients with advanced, crizotinib-treated, anaplastic lymphoma kinase-rearranged NSCLC: Japanese subset2017

    • Author(s)
      Hida Toyoaki、Satouchi Miyako、Nakagawa Kazuhiko、Seto Takashi、Matsumoto Shingo、Kiura Katsuyuki、Nokihara Hiroshi、Murakami Haruyasu、Tokushige Kota、Hatano Ben、Nishio Makoto
    • Journal Title

      Japanese Journal of Clinical Oncology

      Volume: 47 Pages: 618~624

    • DOI

      10.1093/jjco/hyx045

    • Peer Reviewed
  • [Journal Article] Three-Year Follow-Up of an Alectinib Phase I/II Study in ALK-Positive Non-Small-Cell Lung Cancer: AF-001JP2017

    • Author(s)
      Tamura Tomohide、Kiura Katsuyuki、Seto Takashi、Nakagawa Kazuhiko、Maemondo Makoto、Inoue Akira、Hida Toyoaki、Yoshioka Hiroshige、Harada Masao、Ohe Yuichiro、Nogami Naoyuki、Murakami Haruyasu、Kuriki Hiroshi、Shimada Tadashi、Tanaka Tomohiro、Takeuchi Kengo、Nishio Makoto
    • Journal Title

      Journal of Clinical Oncology

      Volume: 35 Pages: 1515~1521

    • DOI

      10.1200/JCO.2016.70.5749

    • Peer Reviewed
  • [Presentation] Acquired resistance to the third-generation EGFR inhibitor ASP8273 is associated with MET or NRAS gene amplifications in preclinical models2017

    • Author(s)
      Kiichiro Ninomiya, Kadoaki Ohashi, Shuta Tomida, Hiroe Kayatani, Tomoki Tamura, Hisao Higo, Go Makimoto, Takashi Ninomiya, Toshio Kubo, Eiki Ichihara, Akiko Sato, Katsuyuki Hotta, Masahiro Tabata, Katsuyuki Kiura.
    • Organizer
      AACR Annual Meeting 2017
    • Int'l Joint Research
  • [Presentation] A comprehensive analysis of autopsied specimens and patient-derived cell lines in ALK-positive lung cancers with rapid acquired resistance to alectinib2017

    • Author(s)
      Go Makimoto, Kadoaki Ohashi, Kazuya Nishii, Shuta Tomida, Hiroe Kayatani, Tomoki Tamura, Hisao Higo, Kiichiro Ninomiya, Takashi Ninomiya, Toshio Kubo, Eiki Ichihara, Akiko Sato, Katsuyuki Hotta, Masahiro Tabata, Katsuyuki Kiura
    • Organizer
      AACR Annual Meeting 2017
    • Int'l Joint Research
  • [Presentation] Clinical Characteristics of Japanese Candidates for Lung Transplant Due to Interstitial Lung Disease and Risk Factors for Early Death While on the Waiting List2017

    • Author(s)
      Hisao Higo , Eiki Ichihara , Takeshi Kurosaki , Kentaroh Miyoshi , Toshio Kubo , Shinji Otani , Seiichiro Sugimoto , Masaomi Yamane , Nobuaki Miyahara , Katsuyuki Kiura , Takahiro Oto
    • Organizer
      American Thoracic Society 2017 International Conference
    • Int'l Joint Research

URL: 

Published: 2018-12-17  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi